Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
Nature Communications|August 16, 2019
Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionSilvia Ottaviani, Justin Stebbing, Adam E Frampton, et al.
Minerva Medica|February 8, 2021
Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE studyTeodora Serban, Roberto Allara, Valeria Azzolini, et al.
Cancer Research|June 11, 2025
Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype ParadigmErica A Oliveira, Salvatore Milite, Javier Fernandez-Mateos, et al.
Blood|January 11, 2022
Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myelomaNikolaos Trasanidis, Alexia Katsarou, Kanagaraju Ponnusamy, et al.
Cell Reports|September 29, 2015
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast CancerManikandan Periyasamy, Hetal Patel, Chun-Fui Lai, et al.
Nature Communications|December 8, 2019
High-resolution label-free 3D mapping of extracellular pH of single living cellsYanjun Zhang, Yasufumi Takahashi, Sung Pil Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast CancerHetal Patel, Rezvan Abduljabbar, Chun-Fui Lai, et al.
Cancer Discovery|March 25, 2024
Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer CellsDalia Rosano, Emre Sofyali, Heena Dhiman, et al.
Cancer Research|October 2, 2024
Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast CancerCarolina Gemma, Chun-Fui Lai, Anup K Singh, et al.
Pageof 20